Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Introduction of mutant TP53 related genes in metabolic pathways and evaluation their correlation with immune cells, drug resistance and sensitivity.

Life sciences - 15 Aug 2022

Motlagh Ali Valipour, Mahdevar Mohammad, Mirzaei Sepideh, Entezari Maliheh, Hashemi Mehrdad, Hushmandi Kiavash, Peymani Maryam

Abstract excerpt

BACKGROUND: Although the relationship between TP53 mutation, TP53 metabolism pathways, and tumorigenesis has been investigated, pan-cancer analysis of TP53 mutations and related metabolism pathways is not completely available in common types of human cancers. Thus, this study was going to represent TP53 mutant-related metabolism genes and pathways in a pan-cancer study and investigate the relationship between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance
Share to Metabolic Networks and Pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasms

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 35667517
DOI: 10.1016/j.lfs.2022.120650

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Introduction of mutant TP53 related genes in metabolic pathways and evaluation their correlation with immune cells, drug resistance and sensitivity.PMID 35667517Read ↗

A novel molecular classification based on TP53 mutation to predict bladder cancer prognosis and immunotherapy efficacySemantic proximity Read ↗

Construction and validation of a prognostic model of metabolism-related genes driven by somatic mutation in bladder cancerSemantic proximity Read ↗

ADH4 Is A TP53-Associated Immune-Metabolic Signature For The Prediction Of Prognosis In Hepatocellular CarcinomaSemantic proximity Read ↗

Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia.Semantic proximity Read ↗

TP53 mutation hits energy metabolism and increases glycolysis in breast cancer.Semantic proximity Read ↗

A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genesSemantic proximity Read ↗

Significance of TP53 Mutation in Cellular Process and Disease Progression in Lung Adenocarcinoma.Semantic proximity Read ↗

Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer.Semantic proximity Read ↗

ADH4 is a TP53-associated immunometabolic signature for prediction of prognosis in hepatocellular carcinomaSemantic proximity Read ↗

A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer.Semantic proximity Read ↗

Construction and Validation of a Prognostic Model of Metabolism-Related Genes Driven by Somatic Mutation in Bladder Cancer.Semantic proximity Read ↗

Deciphering the Controversial Role of TP53 Inducible Glycolysis and Apoptosis Regulator (TIGAR) in Cancer Metabolism as a Potential Therapeutic StrategySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.